Integration of Scaffolds into Full-Thickness Skin Wounds: The Connexin Response

    loading  Checking for direct PDF access through Ovid


Scaffolds have been reported to promote healing of hard-to-heal wounds such as burns and chronic ulcers. However, there has been little investigation into the cell biology of wound edge tissues in response to the scaffolds. Here, we assess the impact of collagen scaffolds on mouse full-thickness wound re-epithelialisation during the first 5 days of healing. We find that scaffolds impede wound re-epithelialisation, inducing a bulbous thickening of the wound edge epidermis as opposed to the thin tongue of migratory keratinocytes seen in normal wound healing. Scaffolds also increase the inflammatory response and the numbers of neutrophils in and around the wound. These effects were also produced by scaffolds made of alginate in the form of fibers and microspheres, but not as an alginate hydrogel. In addition, we find the gap junction protein connexin 43, which normally down-regulates at the wound edge during re-epithelialisation, to be up-regulated in the bulbous epidermal wound edge. Incorporation of connexin 43 antisense oligodeoxynucleotides into the scaffold can be performed to reduce inflammation whilst promoting scaffold biocompatibility.

The in vivo wound healing response to polymer scaffolds at the cell biology level remains little investigated. Here, a variety of scaffolds are applied to wounds and it is found that re-epithelialization is perturbed and the gap junction protein Connexin 43 is deleteriously up-regulated. Through bioactivation of scaffolds using Connexin 43 antisense oligodeoxynucleotides, the biocompatibility of scaffolds for clinical use can be improved.

Related Topics

    loading  Loading Related Articles